Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022 2022-09-02 09:41
Pxierra is launching world's first non-contact heart rate & breathe rate measurement AI baby monitor 2022-09-01 21:00
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management 2022-09-01 19:30
The ECO-Friendly Anti-nausea and Vomiting wristband: Emeterm PLUS 2022-09-01 01:15
AI Startup AESOP Raises $3M to Tackle Medical and Billing Errors 2022-09-01 00:00
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey 2022-08-31 20:00
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc. 2022-08-31 17:05
Nreal Air AR Glasses Receive TÜV Rheinland Eye Comfort (AR) Certification 2022-08-31 10:27
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance 2022-08-31 08:33
Tycoon Group Announces 2022 Interim Results 2022-08-30 22:47
Waterdrop receives the NBD "2022 Green Practice Pioneering Projects" 2022-08-30 22:00
Fosun Pharma Announces 2022 Interim Results 2022-08-30 20:28
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022 2022-08-30 18:00
Kintor Announces 2022 Interim Results and Recent Business Update 2022-08-30 00:19
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences 2022-08-29 21:00
NEXT-GENERATION EGFR TKI H002 FROM REDCLOUD BIO COMPLETES FIRST DOSE IN NON-SMALL CELL LUNG CANCER 2022-08-29 19:30
Porton Advanced and Royaltech Announce Strategic Collaboration to Accelerate the Development of Bacterial Drugs and mRNA Drugs 2022-08-29 12:23
First Vietnam's natural mineral water brand provides perfect alkalinity pH = 9.0 from the premium unique mineral source of Danh Thanh 2022-08-29 10:00
Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation 2022-08-28 08:00
ProSomnus® Sleep Technologies Announces Signing of Definitive Agreements for $30 Million of Convertible Notes 2022-08-27 04:30
1 130 131 132 133 134 801